GAABOR LAUNCHES YEAR END SALE 12.12 VAGANZA
JAKARTA, Indonesia, Dec. 10, 2023 /PRNewswire/ — Gaabor, as a leading household appliance brand in Southeast Asia, always wants to provide an interesting experience with each of its quality products. Join and make life easier with more than one million Indonesians. To complete the range of pro
Studies Uncover Drivers of Health Disparities and Opportunities to Enhance Equity
Research underscores continuing role of demographic factors and comorbidities in blood cancer treatment and research SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Four studies presented during the 65th American Society of Hematology (ASH) Annual Meeting and Exposition examine how demographics and oth
Studies Highlight Impacts of Applying New Technologies in Everyday Care
Findings show benefits of AI-driven techniques, chemotherapy-free treatments, and cell therapy SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Researchers report striking progress in the application of cutting-edge tools and treatments to address longstanding challenges in blood disorders and related h
OnlyFans Search Unveiled: Fanscout’s Groundbreaking New Approach
Fanscout.com addresses the limited search capabilities on OnlyFans by offering a unique solution with real customer reviews, significantly enhancing the discovery and connection process for users and creators. LAS VEGAS, Dec. 9, 2023 /PRNewswire/ — The Challenge of Searching on OnlyFans Naviga
Research Reveals Opportunities to Better Address Blood Disorders Early in Life
Studies point to preventive measures and therapies that can set children on a healthier course with lifelong benefits SAN DIEGO, Dec. 9, 2023 /PRNewswire/ — Researchers report significant progress toward improving access to effective interventions to address blood disorders and promote healthy
Servier Showcases Leadership in Mutant Isocitrate Dehydrogenase (IDH) Inhibition Through New Data Spotlighting Real-World Treatment Patterns and Clinical Outcomes of Tibsovo® Use at ASH 2023
Learn more about Servier’s leadership in mutant IDH inhibition at ASH booth #1347 BOSTON, Dec. 9, 2023 /PRNewswire/ — Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, will be presenting new data in acute myeloid leukemia (AML) at th
COP28: Canada Daily Highlights – December 9, 2023
DUBAI, United Arab Emirates, Dec. 9, 2023 /CNW/ – Daily event and announcement summary Today, Minister Guilbeault took the podium to deliver Canada’s National Statement, highlighting the country’s position, commitments and aspirations for addressing the global climate crisis,
InvaGen Pharmaceuticals Issues Voluntary Nationwide Recall of Vigabatrin for Oral Solution, USP 500mg due to Leaking Sachets
HAUPPAUGE, N.Y., Dec. 9, 2023 /PRNewswire/ — Cipla Limited today announced that its wholly-owned subsidiary, InvaGen Pharmaceuticals Inc. is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP 500mg, to the consumer level. Vigabatrin for Oral Solution, USP 500 mg has been found
New Hybrid Treatment Forces Cancer Cells to Starve
NEW YORK, Dec. 9, 2023 /PRNewswire/ — The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows. The work addressed multiple myeloma, a cancer that forms in blood cells that normally fight infections by making proteins that remove
“MET GALA” FOR LATINOS GATHERED THE MOST IMPORTANT 500+ LATINOS IN THE COUNTRY
The exclusive event honored John Leguizamo, Daytime Emmy award-winning Raúl de Molina and Fashion Designer Anne Fontaine NEW YORK, Dec. 9, 2023 /PRNewswire/ — The We Are All Human Foundation on Dec. 7 commemorated its third Annual We Are All Human Gala—an evening dedicated to mobilizing
